Bavarian Nordic To Sell Priority Review Voucher For $160 Mln, Sees Positive EBITDA Impact; Shares Up
18/6 09:35
(RTTNews) - Danish vaccine company Bavarian Nordic A/S (BVNKF.PK) announced Wednesday that it has entered into an agreement to sell its Priority Review Voucher or PRV for a total cash consideration of $160 million....